Clinical Trials Logo
  1. Home
  2. Rotavirus Infections
  3. NCT00090233

Rotavirus Efficacy and Safety Trial (REST)(V260-006)

Rotavirus Infections Clinical Trial

Official title:
Safety and Efficacy of Pentavalent (G1, G2, G3, G4 , and P1) Human-Bovine Reassortant Rotavirus Vaccine in Healthy Infants

Clinical Trial Summary

This study was designed to evaluate the safety of the investigational rotavirus vaccine and the efficacy to prevent rotavirus gastroenteritis.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00090233
Study type Interventional
Source Merck Sharp & Dohme Corp.
Contact
Status Completed
Phase Phase 3
Start date January 2001
Completion date October 2004
View Details
See also
  Status Clinical Trial Phase
Completed NCT02538211 - The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses N/A
Completed NCT02220439 - Does the Fecal Microbiome Influence Rotarix Immunogenicity N/A
Withdrawn NCT00757926 - Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants Phase 1/Phase 2
Not yet recruiting NCT00484952 - Surveillance of Hospitalizations Due to Rotavirus Infections Among Children From Israel N/A
Completed NCT00092443 - Dose Confirmation Efficacy Study (V260-007) Phase 3
Terminated NCT01357174 - ROTATEQ™ Post-Marketing Surveillance in the Philippines N/A
Recruiting NCT01363726 - Surveillance of Rotavirus Gastroenteritis in Children <5 Years N/A
Completed NCT00130832 - Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED) Phase 3
Recruiting NCT06080906 - Phase II Clinical Trial of the Inactivated Rotavirus Vaccine Phase 2
Recruiting NCT03313128 - SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance
Completed NCT02542462 - Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study Phase 4
Completed NCT00346892 - To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV Phase 2
Not yet recruiting NCT05212935 - A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy
Completed NCT00092456 - Consistency Lots Vaccine Study (V260-009) Phase 3
Completed NCT00981669 - Rotavirus Vaccine Produced by Butantan Institute Phase 1
Completed NCT05037435 - Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years. Phase 3
Completed NCT03483116 - A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine Phase 2
Completed NCT03870061 - Evaluation of an Infant Immunization Encouragement Program in Nigeria N/A
Active, not recruiting NCT05621655 - Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers Phase 2
Completed NCT00280111 - Safety and Immunogenicity Study of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Infants Phase 1